Pivotal Study of the AggreGuide A-100 Adenosine Diphosphate (ADP) Assay to Evaluate the Effect of ADP Blocking Drugs on Platelet Aggregation on the AggreGuide A-100 Instrument
| Status: | Completed |
|---|---|
| Conditions: | Hematology |
| Therapuetic Areas: | Hematology |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 4/2/2016 |
| Start Date: | March 2014 |
| End Date: | May 2014 |
| Contact: | Miguel Posada |
| Email: | miguel_posada@junoresearch.us |
| Phone: | 713-779-5494 |
The study is to characterize the AggreGuide ADP Assay's performance.
Inclusion Criteria:
- 18-75
Exclusion Criteria:
- less than 60 kg
- on antiplatelet meds other than aspirin
- antiplatelet drugs contraindicated
We found this trial at
1
site
